Are low plasma levels of 25-(OH)vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients?

Journal of Nephrology

Volumn 18, Issue 1, 2005, Pages 96-101

  Lomonte, Carlo ^a   Antonelli, Maurizio ^a   Vernaglione, Luigi ^b   Cazzato, Francesco ^a   Casucci, Francesco ^a   Chimienti, Domenico ^a   Bruno, Andrea ^a   Cocola, Savino ^a   Verrelli, Erminia Antonicelli ^a   Basile, Carlo ^a,c  

^a MIULLI GENERAL HOSPITAL   (Italy)

^b Hospital of Manduria   (Italy)

^c NONE   (Italy)

Author keywords

25 (OH)vitamin D; Calcitriol; Parathyroid hormone; Renal transplantation; Secondary hyperparathyroidism

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCITRIOL; CREATININE; ELECTROLYTE; PARATHYROID HORMONE; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN D;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ANALYTICAL PARAMETERS; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIALYSIS; ELECTROLYTE BLOOD LEVEL; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; KOLMOGOROV SMIRNOV TEST; LINEAR REGRESSION ANALYSIS; MALE; METABOLIC DISORDER; MINERAL METABOLISM; MULTIPLE REGRESSION; PARATHYROID HORMONE BLOOD LEVEL; PATIENT MONITORING; PATIENT SELECTION; PHOSPHATE BLOOD LEVEL; PREDICTION; PROTEINURIA; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM; STATISTICAL SIGNIFICANCE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; BLOOD; CROSS-SECTIONAL STUDY; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSMOLARITY; POSTOPERATIVE PERIOD; STATISTICAL MODEL;

ADULT; CALCITRIOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY TRANSPLANTATION; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSMOLAR CONCENTRATION; PARATHYROID HORMONE; POSTOPERATIVE PERIOD; RISK FACTORS; VITAMIN D;

EID: 16844382164     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Locatelli F, Cannata-Andia JB, Drüeke TB, Hörl WH, Fouque D, Heimburger O, Ritz E. Management of disturbance of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. Nephrol Dial Transplant 2002; 17: 723-91.
2. Schömig M, Ritz E. Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites. Nephrol Dial Transplant 2000; 15 (suppl 5): S18-24.
3. Ghazali A, Fardellone P, Pruna A, Atik A, Achard J-M, Oprisiu R, Brazier M, Remond A, Morinière P, Garabedian M, Eastwood J, Fournier A. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol? Kidney Int 1999; 55: 2169-77.
4. National Kidney Foundation: K-DOQI clinical practice guidelines for bone metabolism and disease. Am J Kidney Dis 2003; 42 (suppl 3): S7-201.
5. De Sévaux RG, Hoitsma AJ, van Hood HJ, Corstens FJ, Wetzels JF. Abnormal vitamin D metabolism and loss of bone mass after renal transplantation. Nephron Clin Pract 2003; 93: C21-8.
6. Gomez Alonso G, Naves Diaz M, Rodriguez Garcia M, Fernandez M, Cannata Andia JB. Review of the concept of vitamin D "sufficiency and insufficiency". Nefrologia 2003; 23 (suppl 2): S73-7.
7. Reinhardt W, Bartelworth H, Jockenhövel F, Schmidt-Gayk H, Witzke O, Wagner K, Heemann UW, Reinwein D, Philipp T, Mann K. Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transplant 1998; 13: 436-42.
8. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003; 89: 552-72.
9. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS. Hypovitaminosis in medical inpatients. N Engl J Med 1998; 338: 777-83.
10. Rucker D, Allan JA, Fick GH, Hanley DA. Vitamin D insufficiency in a population of healthy western Canadians. Can Med Assoc J 2002; 166: 1517-24.
11. Coburn JW. An update on vitamin D as related to nephrology practice: 2003. Kidney Int 2003; 64 (suppl 87): S125-30.
12. Evenepoel P, Claes K, Kuypers D, Maes B, Bammens B, Vanrenterghem Y. Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single centre study. Nephrol Dial Transplant 2004; 19: 1281-7.
13. Messa P, Sindici C, Cannella G, Miotti V, Risaliti A, Gropuzzo M, Di Loreto PL, Bresadola M, Mioni G. Persistent secondary hyperparathyroidism after renal transplantation. Kidney Int 1998; 54: 1704-13
14. Saha HH, Salmela KT, Ahonen PJ, Pietila KO, Morsky PJ, Mustonen JT, Lalla ML, Pasternack AI. Sequential changes in vitamin D and calcium metabolism after successful renal transplantation. Scan J Urol Nephrol 1994; 28: 21-7.
15. Briner VA, Thiel G, Monier-Faugere MC, Bognar B, Landmann J, Kamber V, Malluche HH. Prevention of cancellous bone loss but persistence of renal bone disease despite normal 1,25 vitamin D levels two years after kidney transplantation. Transplantation 1995; 59: 1393-400.
16. Stein B, Halloran BP, Reinhardt T, Engstrom GW, Bales CW, Drezner MK, Currie KL, Takizawa M, Adams JS, Epstein S. Cyclosporin-A increases synthesis of 1,25-dihydroxyvitamin D3 in the rat and mouse. Endocrinology 1991; 128: 1369-73.
17. Ishimura E, Nishizawa Y, Inaba M, Matsumoto N, Emoto M, Kawagishi T, Shoji S, Okuno S, Kim M, Miki T, Morii H. Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int 1999; 55: 1019-27.
18. Hilpert J, Wogensen L, Thykjaer T, Welner M, Schlichting U, Orntft TF, Bachmann S, Nykjaer A, Willnow TE. Expression profiling confirms role of endocytic receptor megalin in renal vitamin D3 metabolism. Kidney Int 2002; 62: 1672-81.
19. Takemoto F, Shinki T, Yokoyama K, Inokami T, Hara S, Yamada A, Kurokawa K, Uchida S. Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats. Kidney Int 2003; 64: 414-20.